Literature DB >> 32747555

Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice.

Qiong Liu1,2,3, Siying Cheng1,2, Huiming Yang2, Louyin Zhu2, Yongcheng Pan2,3, Liang Jing4, Beisha Tang1,3,5,6, Shihua Li7, Xiao-Jiang Li8.   

Abstract

Huntington disease (HD) is an ideal model for investigating selective neurodegeneration, as expanded polyQ repeats in the ubiquitously expressed huntingtin (HTT) cause the preferential neurodegeneration in the striatum of the HD patient brains. Here we report that adeno-associated virus (AAV) transduction-mediated depletion of Hap1, the first identified huntingtin-associated protein, in adult HD knock-in (KI) mouse brains leads to selective neuronal loss in the striatum. Further, Hap1 depletion-mediated neuronal loss via AAV transduction requires the presence of mutant HTT. Rhes, a GTPase that is enriched in the striatum and sumoylates mutant HTT to mediate neurotoxicity, binds more N-terminal HTT when Hap1 is deficient. Consistently, more soluble and sumoylated N-terminal HTT is presented in HD KI mouse striatum when HAP1 is absent. Our findings suggest that both Rhes and Hap1 as well as cellular stress contribute to the preferential neurodegeneration in HD, highlighting the involvement of multiple factors in selective neurodegeneration.

Entities:  

Keywords:  aggregates; huntingtin-associated protein; neurodegeneration; polyglutamine; sumoylation

Mesh:

Substances:

Year:  2020        PMID: 32747555      PMCID: PMC7443904          DOI: 10.1073/pnas.2002283117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  Light and electron microscopic characterization of the evolution of cellular pathology in HdhQ92 Huntington's disease knock-in mice.

Authors:  Zubeyde Bayram-Weston; Lesley Jones; Stephen B Dunnett; Simon P Brooks
Journal:  Brain Res Bull       Date:  2011-04-13       Impact factor: 4.077

2.  Indications for cell stress in response to adenoviral and baculoviral gene transfer observed by proteome profiling of human cancer cells.

Authors:  Christopher Gerner; Verena J Haudek-Prinz; Andreas Lackner; Annemarie Losert; Barbara Peter-Vörösmarty; Olga Lorenz; Michael Grusch
Journal:  Electrophoresis       Date:  2010-06       Impact factor: 3.535

3.  The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.

Authors:  Yvette C Wong; Erika L F Holzbaur
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

4.  Immunohistochemical analysis of huntingtin-associated protein 1 in adult rat spinal cord and its regional relationship with androgen receptor.

Authors:  Md Nabiul Islam; Yukio Takeshita; Akie Yanai; Amami Imagawa; Mir Rubayet Jahan; Greggory Wroblewski; Joe Nemoto; Ryutaro Fujinaga; Koh Shinoda
Journal:  Neuroscience       Date:  2016-10-29       Impact factor: 3.590

Review 5.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

Review 6.  Regulation of intracellular HAP1 trafficking.

Authors:  Juan Rong; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Neurosci Res       Date:  2007-11-01       Impact factor: 4.164

7.  Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.

Authors:  Robert G Mealer; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

8.  Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.

Authors:  Shi-Hua Li; Zhao-Xue Yu; Cui-Lin Li; Huu-Phuc Nguyen; Yong-Xing Zhou; Chuxia Deng; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

9.  Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Liliana B Menalled; Jessica D Sison; Ioannis Dragatsis; Scott Zeitlin; Marie-Françoise Chesselet
Journal:  J Comp Neurol       Date:  2003-10-06       Impact factor: 3.215

10.  Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.

Authors:  Brandon A Baiamonte; Franklin A Lee; Steve T Brewer; Daniela Spano; Gerald J LaHoste
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

View more
  9 in total

Review 1.  CRISPR-Based Genome-Editing Tools for Huntington's Disease Research and Therapy.

Authors:  Yiyang Qin; Shihua Li; Xiao-Jiang Li; Su Yang
Journal:  Neurosci Bull       Date:  2022-05-24       Impact factor: 5.203

2.  Immunohistochemical expression and neurochemical phenotypes of huntingtin-associated protein 1 in the myenteric plexus of mouse gastrointestinal tract.

Authors:  Abu Md Mamun Tarif; Md Nabiul Islam; Mir Rubayet Jahan; Akie Yanai; Kanako Nozaki; Koh-Hei Masumoto; Koh Shinoda
Journal:  Cell Tissue Res       Date:  2021-10-19       Impact factor: 5.249

3.  Impaired XK recycling for importing manganese underlies striatal vulnerability in Huntington's disease.

Authors:  Gaurav Chhetri; Yuting Ke; Ping Wang; Muhammad Usman; Yan Li; Ellen Sapp; Jing Wang; Arabinda Ghosh; Md Ariful Islam; Xiaolong Wang; Adel Boudi; Marian DiFiglia; Xueyi Li
Journal:  J Cell Biol       Date:  2022-09-13       Impact factor: 8.077

4.  Sequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway.

Authors:  Sydney E Cason; Peter J Carman; Claire Van Duyne; Juliet Goldsmith; Roberto Dominguez; Erika L F Holzbaur
Journal:  J Cell Biol       Date:  2021-05-20       Impact factor: 8.077

5.  Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease.

Authors:  Mehdi Eshraghi; Pabalu P Karunadharma; Juliana Blin; Neelam Shahani; Emiliano P Ricci; Audrey Michel; Nicolai T Urban; Nicole Galli; Manish Sharma; Uri Nimrod Ramírez-Jarquín; Katie Florescu; Jennifer Hernandez; Srinivasa Subramaniam
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

Review 6.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

7.  Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease.

Authors:  Uri Nimrod Ramírez-Jarquín; Manish Sharma; Wuyue Zhou; Neelam Shahani; Srinivasa Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-01       Impact factor: 12.779

Review 8.  SUMO-modifying Huntington's disease.

Authors:  Ericks S Soares; Rui D Prediger; Patricia S Brocardo; Helena I Cimarosti
Journal:  IBRO Neurosci Rep       Date:  2022-03-09

Review 9.  Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.

Authors:  Marcello Serra; Annalisa Pinna; Giulia Costa; Alessandro Usiello; Massimo Pasqualetti; Luigi Avallone; Micaela Morelli; Francesco Napolitano
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.